FUSION PHARMACEUTICALS INC's ticker is FUSN and the CUSIP is 36118A100. A total of 38 filers reported holding FUSION PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $80,256 | -43.5% | 30,868 | +1.6% | 0.00% | – |
| Q2 2023 | $142,150 | +50.0% | 30,374 | +20.8% | 0.00% | – |
| Q1 2023 | $94,762 | +119851.9% | 25,136 | 0.0% | 0.00% | – |
| Q4 2022 | $79 | -99.9% | 25,136 | 0.0% | 0.00% | – |
| Q3 2022 | $75,000 | +21.0% | 25,136 | 0.0% | 0.00% | – |
| Q2 2022 | $62,000 | -68.2% | 25,136 | 0.0% | 0.00% | – |
| Q1 2022 | $195,000 | +87.5% | 25,136 | 0.0% | 0.00% | – |
| Q4 2021 | $104,000 | -47.7% | 25,136 | 0.0% | 0.00% | – |
| Q3 2021 | $199,000 | +7.0% | 25,136 | +8.9% | 0.00% | – |
| Q2 2021 | $186,000 | -24.7% | 23,089 | 0.0% | 0.00% | – |
| Q1 2021 | $247,000 | -8.9% | 23,089 | 0.0% | 0.00% | – |
| Q4 2020 | $271,000 | -2.2% | 23,089 | 0.0% | 0.00% | – |
| Q3 2020 | $277,000 | – | 23,089 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,670,516 | $9,543,342 | 3.52% |
| ADAMS STREET PARTNERS LLC | 2,947,809 | $7,664,303 | 2.68% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,560,982 | $4,058,553 | 1.62% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,354,258 | $3,521,071 | 0.64% |
| Avidity Partners Management LP | 5,781,850 | $15,032,810 | 0.60% |
| Eagle Health Investments LP | 579,769 | $1,507,399 | 0.33% |
| Perceptive Advisors | 2,751,395 | $7,153,627 | 0.24% |
| Ghost Tree Capital, LLC | 243,287 | $632,546 | 0.21% |
| Sio Capital Management, LLC | 246,036 | $639,694 | 0.20% |
| Artal Group S.A. | 1,725,000 | $4,485 | 0.19% |